Skip to main content

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Investor Securities Class Action Lawsuit 02/09/2024

  • If you purchased shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), you have certain options. NASDAQ: AMLX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 04, 2026 - The court granted preliminary approval of the settlement. September 30, 2025 - The court denied the defendants' motion to dismiss the case. September 06, 2024 - the defendants filed their motions to dismiss the amended complaint. June 24, 2024 - An amended complaint was filed. February 09, 2024 - An investor in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) filed...



You must register (for free) or login to view the entire case.